C O M M U N I C A T I O N S
Waller, G. R., Yamasaki, K., Eds.; Plenum Press: New York, 1996; pp
129-149. (d) Tran, Q. L.; Adnyana, I. K.; Tezuka, Y.; Nagaoka, T.; Tran,
Q. K.; Kadota, S. J. Nat. Prod. 2001, 64, 456-461. (e) Fu, L.; Zhang, S.;
Li, N.; Wang, J.; Zhao, M.; Sakai, J.; Hasegawa, T.; Mitsui, T.; Kataoka,
T.; Oka, S.; Kiuchi, M.; Hirose K.; Ando, M. J. Nat. Prod. 2005, 68,
198-206. (f) Betancor, C.; Freire, R.; Hernandez, R.; Suarez, E.; Cortes,
M.; Prange, T.; Pascard, C. J. Chem. Soc., Perkin Trans. 1 1983, 1119-
1126.
side chain of the dammarenyl cation (4) in lupeol synthesis should
also have rotational mobility and a partially extended conformation.
Oxacyclic triterpenes, such as 8-9b, are presumably generated
by all eukaryotes having pentacyclic triterpene synthases15 since
DOS is ubiquitous as a minor byproduct of OS biosynthesis. Low
physiological concentrations of 8 and 9a are suggested by their
rarity in natural product isolations and by the generally limited
metabolic flux through the DOS shunt pathway. Variations in trace
levels of 24,25-epoxycholesterol, a DOS metabolite, indirectly
monitor enzyme activities and are used to regulate transcription in
mammalian cholesterol homeostasis.2a,e,16 Levels of diols 8 and 9a
also reflect epoxidase/cyclase activity and may similarly serve as
regulators of triterpenoid synthesis.
Diol 9b may be produced in nature at much higher levels than
8 or 9a. Epoxydammarane and dammarenediol saponins commonly
occur together and generally have a 20S configuration. A dam-
marenediol synthase could make 3â,20S-dammarenediol from OS
and the 20S,24S-epoxydammarane 9b from DOS. The active site
of dammarenediol synthases, unlike that of LUP1, evidently
obstructs the re face of C20 to exclude E ring formation, and this
would block formation of 8 and 9a. DOS cyclization might also
produce 24R-epoxydammaranes in dammarenediol synthases, as
indicated in the conversion of 5 to 9c.17 However, our isolation of
epoxydammaranes as DOS metabolites does not preclude their
origin from other pathways. For example, cycloartenol analogues
of epoxydammaranes18 must arise from post-cyclization oxidation
because DOS cyclization cannot generate both cyclopropyl and
heterocyclic rings. Similar oxidation by P450s and other oxidases
may have evolved to become the major biosynthetic route to
epoxydammaranes in many plants.1c,19 The best current evidence
for the DOS pathway in secondary metabolism is the isolation of
17,24-epoxybaccharanes20a and olefinic epoxydammaranes,20b struc-
tures that are unlikely products of P450 pathways.
To model how readily oxacycles could arise in vivo, we
expressed JR1.16 in the yeast lanosterol synthase mutant SMY8.
Cultures of SMY8[JR1.16] accumulated 8, 9a, and 9b at a level of
2-7% of the OS products.21 This experimental system evidently
made considerable DOS available to LUP1 for oxacycle formation.22
The crude squalene epoxidase/oxidosqualene cyclase systems that
first evolved probably also generated substantial amounts of
oxacycles. The oxacyclic triterpenoids produced by these unopti-
mized early systems may have provided aglycones for saponin
synthesis until an efficient cluster of P450s evolved. This could
explain how natural selection began assembling saponin synthesis,
a multistep process in which the individual components lack
biological activity. The use of alternative substrates23 exemplifies
one of several strategies used by plants and fungi to increase the
diversity of secondary metabolites.24 The genetic foundation for
artificial and native metabolic engineering may be broader than is
evident from natural products surveys and genomic analyses.
(2) (a) Spencer, T. A. Acc. Chem. Res. 1994, 27, 83-90. (b) Field, R. B.;
Holmlund, C. E. Arch. Biochem. Biophys. 1977, 180, 465-471. (c) Lorenz,
R. T.; Parks, L. W. J. Bacteriol. 1987, 169, 3707-3711. (d) Bai, M.;
Xiao, X.; Prestwich, G. D. Biochem. Biophys. Res. Commun. 1992, 185,
323-329. (e) Rowe, A. H.; Argmann, C. A.; Edwards, J. Y.; Sawyez, C. G.;
Morand, O. H.; Hegele, R. A.; Huff, M. W Circ. Res. 2003, 93, 717-
725.
(3) (a) Corey, E. J.; Gross, S. K. J. Am. Chem. Soc. 1967, 89, 4561-4562.
A lanosterol synthase prefers DOS over OS: (b) Boutaud, O.; Dolis, D.;
Schuber, F. Biochem. Biophys. Res. Commun. 1992, 188, 898-904. A
dammarenyl-type cyclase also readily accepts DOS: (c) Fazio, G. C.;
Xu, R.; Matsuda, S. P. T. J. Am. Chem. Soc. 2004, 126, 5678-5679.
(4) Heterocyclic triterpenes have never been reported from DOS but are
evidently formed in marine organisms by reaction of epoxides with a
cationic intermediate: (a) Valentine, J. C.; McDonald, F. E.; Neiwert, W. A.;
Hardcastle, K. I. J. Am. Chem. Soc. 2005, 127, 4586-4587. (b) Carter-
Franklin, J. N.; Butler, A. J. Am. Chem. Soc. 2005, 127, 15060-15061.
(c) Connolly, J. D.; Hill, R. A. Nat. Prod. Rep. 2003, 20, 640-659.
(5) (a) Herrera, J. B.; Bartel, B.; Wilson, W. K.; Matsuda, S. P. T.
Phytochemistry 1998, 49, 1905-1911. (b) Segura, M. J. R.; Meyer, M.
M.; Matsuda, S. P. T. Org. Lett. 2000, 2, 2257-2259.
(6) Identification of terminal olefins from NMR spectra was tentative owing
to their small amounts and coelution with other substances. The favored
quenching of oxonium ions 10-12 by attack of water rather than by
deprotonation is discussed in Supporting Information.
(7) Silica gel chromatography gave 8 (1.5 mg, Rf 0.31, 1:1 MTBE/hexane)
and a mixture of 9a and 9b (3 mg, Rf 0.37). Reversed phase HPLC was
done with a mobile phase of 9:1 MeOH/H2O.
(8) (a) GC-MS fragmentation of mono- and bis-TMS derivatives indicated
hydroxyl at C25 and an ether linkage at C24. An abundant ion at m/z 383
in 8 pointed to a stable ring skeleton derived from neutral losses of
TMSOH and the hydroxyisopropyl group. Epoxydammaranes 9a and 9b
coeluted on GC and had identical mass spectra. Their base peak at m/z
143 is characteristic of epoxydammaranes,1a and ion m/z 383 excluded
the possibility of a six-membered E ring. (b) NOE experiments indicated
that the C20 methyl and H24 proton are located on the same side of the
E ring plane in 9a and on different sides in 9b.
(9) (a) Hisham, A.; Ajitha Bai, M. D.; Fumimoto, Y.; Hara, N.; Shimada, H.
Magn. Reson. Chem. 1996, 34, 146-150. (b) Tanaka, R.; Masuda, K.;
Matsunaga, S. Phytochemistry 1993, 32, 472-74. (c) Reported NMR data
are critically reviewed with structure revisions in Supporting Information.
(10) The lack of epimerization at C17 is discussed in Supporting Information.
(11) Side chain rotation and oxonium ion formation were modeled by DFT
methods using Gaussian software: Frisch, M. J.; et al. Gaussian 03,
revision C.02; Gaussian, Inc.: Wallingford, CT, 2003. Bonds from oxygen
to C20, C24, and C25 in 11 were 1.59, 1.50, and 1.59 Å (B3LYP/6-31G*
geometry). In the absence of enzymatic effects, activation enthalpies for
side chain rotation or D ring expansion from 5 were ca. 5 versus 16 kcal/
mol for D ring expansion from 11; see Supporting Information.
(12) (a) Wendt, K. U.; Schulz, G. E.; Corey, E. J.; Liu, D. R. Angew. Chem.,
Int. Ed. 2000, 39, 2812-2833. (b) Xu, R.; Fazio, G. C.; Matsuda, S. P.
T. Phytochemistry 2004, 65, 261-291.
(13) Hopene-type folding in LUP1 is unlikely, and lupeol-type folding would
produce only 9a. See Supporting Information for further details.
(14) Reinert, D. J.; Balliano, G.; Schulz, G. E. Chem. Biol. 2004, 11, 121-
126.
(15) Isomers of 8-9b would be produced by eukaryotic cyclases that make
hopane or protostane pentacycles; see Supporting Information.
(16) (a) Wong, J.; Quinn, C. M.; Brown, A. J. Arterioscler. Thromb. Vasc.
Biol. 2004, 24, 2365-2371. (b) Huff, M. W.; Telford, D. E. Trends
Pharmacol. Sci. 2005 26, 335-340.
(17) 24R-Epoxydammaranes can also arise during sample processing by
autoxidation of (20S)-dammar-24-ene-3â,20-diol, as occurs in the drying
of varnishes containing dammar resin triterpenes: van der Doelen, G.
A.; Boon, J. J. J. Photochem. Photobiol. A: Chem. 2000, 134, 45-57.
(18) Matsubara, C.; de Vivar, A. R. Phytochemistry 1985, 24, 613-615.
(19) Epoxydammarane biosynthesis: (a) Harrison, D. M. Nat. Prod. Rep. 1990,
7, 459-484. (b) Jung, J. D.; Park, H.-W.; Hahn, Y.; Hur, C.-G.; In, D.
S.; Chung, H.-J.; Liu, J. R.; Choi, D.-W. Plant Cell Rep. 2003, 22, 224-
230.
Acknowledgment. We thank the Robert A. Welch Foundation
(C-1323), the NSF (MCB-0209769), and the Herman Frasch
Foundation for funding.
Supporting Information Available: Complete refs 11 and 20a;
details of substrate preparation, enzymatic cyclization, molecular
modeling, NMR signal assignments, and GC-MS and NMR spectra
of 8, 9a, and 9b (PDF). This material is available free of charge via
(20) (a) Hwang, B. Y.; et al. J. Org. Chem. 2004, 69, 3350-3358. Erratum
6156. (b) Aalbersberg, W.; Singh, Y. Phytochemistry 1991, 30, 921-
926.
(21) (a) Details are given in Supporting Information. Unlike RXY6[JR1.16],
SMY8[JR1.16] contains squalene epoxidase and thus produces OS. (b)
Traces of 8 can be seen in the published NMR spectrum of lupanediol.5b
(22) Possible factors affecting the relative levels of DOS and OS and the
availability of DOS to cyclases are discussed in Supporting Information.
(23) (a) Xiong, Q.; Zhu, X.; Wilson, W. K.; Ganesan, A.; Matsuda, S. P. T. J.
Am. Chem. Soc. 2003, 125, 9002-9003. (b) Hoshino, T.; Kumai, Y.; Kudo,
I.; Nakano S.; Ohashi, S. Org. Biomol. Chem. 2004, 2, 2650-2657.
(24) Firn, R. D.; Jones, C. G. Nat. Prod. Rep. 2003, 20, 382-391.
References
(1) (a) Tanaka, O.; Yahara, S. Phytochemistry 1978, 17, 1353-1358. (b) Zou,
K.; Zhu, S.; Tohda, C.; Cai, S.; Komatsu, K. J. Nat. Prod. 2002, 65, 346-
351. (c) Duc, N. M.; Kasai, R.; Ohtani, K.; Ito, A.; Yamasaki, K.; Nham,
N. T.; Tanaka, O. In Saponins Used in Traditional and Modern Medicine;
JA055822G
9
J. AM. CHEM. SOC. VOL. 127, NO. 51, 2005 18009